Kirk E. Hevener
Impact in
-
- Computational Drug Discovery Methods
- Toxicology top 2%
Papers in
-
- Biochemical and Molecular Research 7
- Cancer therapeutics and mechanisms 7
-
- Clostridium difficile and Clostridium perfringens research 8
- Co-authors
- Richard Lee (10 shared papers)Stephen W. White (3 shared papers)David M. Ball (2 shared papers)Jianjun Qi (2 shared papers)Kerim Babaoglu (2 shared papers)Michael E. Johnson (13 shared papers)Wei Zhao (1 shared paper)Shahila Mehboob (6 shared papers)
- Journals
- Journal of Medicinal Chemistry (6 papers)ACS Infectious Diseases (4 papers)Antimicrobial Agents and Chemotherapy (4 papers)Protein Expression and Purification (3 papers)Bioorganic & Medicinal Chemistry (3 papers)
- Partner nations
- United StatesSpainChina
In The Last Decade
Kirk E. Hevener
44 papers receiving 1.8k citations
Kirk E. Hevener's Hit Papers
Peers
Comparison fields: 5 of 108
- Computational Theory and Mathematics 520
- Toxicology 79
- Infectious Diseases 333
- Molecular Medicine 77
- Organic Chemistry 461
Countries citing papers authored by Kirk E. Hevener
This map shows the geographic impact of Kirk E. Hevener's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kirk E. Hevener with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kirk E. Hevener more than expected).
Fields of papers citing papers by Kirk E. Hevener
This network shows the impact of papers produced by Kirk E. Hevener. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kirk E. Hevener. The network helps show where Kirk E. Hevener may publish in the future.
Co-authors
The 25 scholars most cited alongside Kirk E. Hevener, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Validation of Molecular Docking Programs for Virtual Screening against Dihydropteroate Synthase Hit paper breakdown → | 2009 | 480 |
| 2 | 2013 | 200 | |
| 3 | 2018 | 184 | |
| 4 | 2015 | 104 | |
| 5 | 2009 | 82 | |
| 6 | 2004 | 82 | |
| 7 | 2009 | 78 | |
| 8 | 2005 | 55 | |
| 9 | 2011 | 52 | |
| 10 | 2019 | 51 | |
| 11 | 2004 | 48 | |
| 12 | 2008 | 45 | |
| 13 | 2023 | 31 | |
| 14 | 2019 | 27 | |
| 15 | 2018 | 24 | |
| 16 | 2018 | 24 | |
| 17 | 2018 | 24 | |
| 18 | 2013 | 19 | |
| 19 | 2015 | 19 | |
| 20 | 2012 | 18 |
About Kirk E. Hevener
Kirk E. Hevener is a scholar working on Molecular Biology, Infectious Diseases, Organic Chemistry, Epidemiology and Computational Theory and Mathematics, having authored 44 papers that have together received 1.9k indexed citations. Recurring topics across this work include Clostridium difficile and Clostridium perfringens research (8 papers), Biochemical and Molecular Research (7 papers), Cancer therapeutics and mechanisms (7 papers), Antimicrobial agents and applications (6 papers), Computational Drug Discovery Methods (6 papers), Nosocomial Infections in ICU (5 papers), Pneumocystis jirovecii pneumonia detection and treatment (5 papers) and Antibiotic Resistance in Bacteria (4 papers). The work is most often cited by research in Computational Theory and Mathematics (520 citations), Toxicology (79 citations), Infectious Diseases (333 citations), Molecular Medicine (77 citations) and Organic Chemistry (461 citations). Kirk E. Hevener has collaborated with scholars based in United States, Spain and China. Frequent co-authors include Richard Lee, Stephen W. White, David M. Ball, Jianjun Qi, Kerim Babaoglu, Michael E. Johnson, Wei Zhao, Shahila Mehboob, Julian G. Hurdle and Tian Ran Zhu. Their work appears in journals such as Journal of Medicinal Chemistry, ACS Infectious Diseases, Antimicrobial Agents and Chemotherapy, Protein Expression and Purification and Bioorganic & Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.